|
May 14
|
Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters
|
|
May 14
|
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
|
|
May 13
|
RBC Noes Bausch Health Filing For Rehearing in Appellate Court
|
|
May 9
|
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
|
|
May 6
|
Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
|
|
May 3
|
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
|
|
May 2
|
Why Bausch Health Companies Stock Dived by More Than 7% Today
|
|
May 2
|
Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst ...
|
|
May 2
|
Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates
|
|
May 2
|
Bausch Health Announces First Quarter 2024 Results
|
|
May 1
|
Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance
|
|
Apr 29
|
All You Need to Know About Bausch (BHC) Rating Upgrade to Buy
|
|
Apr 25
|
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
|
|
Apr 24
|
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 23
|
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
|
|
Apr 20
|
10 Best Healthcare Stocks to Buy Under $20
|
|
Apr 11
|
Bausch Health to Announce First-Quarter 2024 Results on May 2
|
|
Apr 11
|
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
|